Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.85
-0.03 (-0.44%)
At close: Mar 6, 2026, 4:00 PM EST
6.80
-0.05 (-0.73%)
After-hours: Mar 6, 2026, 4:18 PM EST
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $178.12 million as of March 6, 2026. Its market cap has decreased by -64.69% in one year.
Market Cap
178.12M
Enterprise Value
47.34M
1-Year Change
-64.69%
Ranking
Category
Stock Price
$6.85
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $178.12M, an increase of 7.26%. That is a compound annual growth rate of 3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 178.12M | -4.99% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 183.78M |
| NeOnc Technologies Holdings | 183.64M |
| SAB Biotherapeutics | 181.38M |
| Kalaris Therapeutics | 180.95M |
| ProQR Therapeutics | 178.03M |
| Canton Strategic Holdings | 177.88M |
| Tenaya Therapeutics | 177.38M |
| Sagimet Biosciences | 177.24M |